BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26334103)

  • 1. Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure.
    Colombo PE; du Manoir S; Orsett B; Bras-Gonçalves R; Lambros MB; MacKay A; Nguyen TT; Boissière F; Pourquier D; Bibeau F; Reis-Filho JS; Theillet C
    Oncotarget; 2015 Sep; 6(29):28327-40. PubMed ID: 26334103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse.
    du Manoir S; Orsetti B; Bras-Gonçalves R; Nguyen TT; Lasorsa L; Boissière F; Massemin B; Colombo PE; Bibeau F; Jacot W; Theillet C
    Mol Oncol; 2014 Mar; 8(2):431-43. PubMed ID: 24394560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.
    Heo EJ; Cho YJ; Cho WC; Hong JE; Jeon HK; Oh DY; Choi YL; Song SY; Choi JJ; Bae DS; Lee YY; Choi CH; Kim TJ; Park WY; Kim BG; Lee JW
    Cancer Res Treat; 2017 Oct; 49(4):915-926. PubMed ID: 28052650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
    Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
    Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
    Lawrence MG; Pook DW; Wang H; Porter LH; Frydenberg M; Kourambas J; Appu S; Poole C; Beardsley EK; Ryan A; Norden S; Papargiris MM; Risbridger GP; Taylor RA
    Prostate; 2015 Sep; 75(13):1475-83. PubMed ID: 26177841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
    Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating patient-derived colorectal cancer xenografts as preclinical models by comparison with patient clinical data.
    Nunes M; Vrignaud P; Vacher S; Richon S; Lièvre A; Cacheux W; Weiswald LB; Massonnet G; Chateau-Joubert S; Nicolas A; Dib C; Zhang W; Watters J; Bergstrom D; Roman-Roman S; Bièche I; Dangles-Marie V
    Cancer Res; 2015 Apr; 75(8):1560-6. PubMed ID: 25712343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations.
    Ricci F; Bizzaro F; Cesca M; Guffanti F; Ganzinelli M; Decio A; Ghilardi C; Perego P; Fruscio R; Buda A; Milani R; Ostano P; Chiorino G; Bani MR; Damia G; Giavazzi R
    Cancer Res; 2014 Dec; 74(23):6980-90. PubMed ID: 25304260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian and cervical cancer patient derived xenografts: The past, present, and future.
    Boone JD; Dobbin ZC; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2015 Aug; 138(2):486-91. PubMed ID: 26026736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma.
    Landuzzi L; Manara MC; Lollini PL; Scotlandi K
    Cells; 2021 Feb; 10(2):. PubMed ID: 33671173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived xenografts undergo mouse-specific tumor evolution.
    Ben-David U; Ha G; Tseng YY; Greenwald NF; Oh C; Shih J; McFarland JM; Wong B; Boehm JS; Beroukhim R; Golub TR
    Nat Genet; 2017 Nov; 49(11):1567-1575. PubMed ID: 28991255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Genomically Characterized Collection of High-Grade Serous Ovarian Cancer Xenografts for Preclinical Testing.
    Cybulska P; Stewart JM; Sayad A; Virtanen C; Shaw PA; Clarke B; Stickle N; Bernardini MQ; Neel BG
    Am J Pathol; 2018 May; 188(5):1120-1131. PubMed ID: 29458007
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    D'Ambrosio C; Erriquez J; Arigoni M; Capellero S; Mittica G; Ghisoni E; Borella F; Katsaros D; Privitera S; Ribotta M; Maldi E; Di Nardo G; Berrino E; Venesio T; Ponzone R; Vaira M; Hall D; Jimenez-Linan M; Paterson AL; Calogero RA; Brenton JD; Valabrega G; Di Renzo MF; Olivero M
    Cells; 2020 Feb; 9(2):. PubMed ID: 32075097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods.
    Alkema NG; Tomar T; Duiker EW; Jan Meersma G; Klip H; van der Zee AG; Wisman GB; de Jong S
    Sci Rep; 2015 Oct; 5():14495. PubMed ID: 26440065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
    Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
    J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.
    Kanaya N; Somlo G; Wu J; Frankel P; Kai M; Liu X; Wu SV; Nguyen D; Chan N; Hsieh MY; Kirschenbaum M; Kruper L; Vito C; Badie B; Yim JH; Yuan Y; Hurria A; Peiguo C; Mortimer J; Chen S
    J Steroid Biochem Mol Biol; 2017 Jun; 170():65-74. PubMed ID: 27154416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis.
    Wang J; Xing B; Liu W; Li J; Wang X; Li J; Yang J; Ji C; Li Z; Dong B; Gao J; Shen L
    Theranostics; 2019; 9(12):3485-3500. PubMed ID: 31281492
    [No Abstract]   [Full Text] [Related]  

  • 18. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
    Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M
    Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones.
    Tew BY; Legendre C; Schroeder MA; Triche T; Gooden GC; Huang Y; Butry L; Ma DJ; Johnson K; Martinez RA; Pierobon M; Petricoin EF; O'shaughnessy J; Osborne C; Tapia C; Buckley DN; Glen J; Bernstein M; Sarkaria JN; Toms SA; Salhia B
    Neuro Oncol; 2020 Jan; 22(1):70-83. PubMed ID: 31433055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Xenotransplantation Site on MicroRNA Expression of Human Colon Cancer Stem Cells.
    Mukohyama J; Shimono Y; Yamashita K; Sumi Y; Mukohara T; Minami H; Kakeji Y
    Anticancer Res; 2016 Jul; 36(7):3679-86. PubMed ID: 27354640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.